Stefan Menzl
Plus aucun poste en cours
Profil
Stefan Menzl worked as a Chief Executive Officer at Micro-Motor AG and as a Chief Technology Officer at coramaze technologies GmbH.
Anciens postes connus de Stefan Menzl
| Sociétés | Poste | Fin |
|---|---|---|
coramaze technologies GmbH
 coramaze technologies GmbH Medical SpecialtiesHealth Technology coramaze technologies GmbH operates as a medical device company which develops valve repair system. It offers mitramaze a novel concept for transcatheter mitral valve repair intended for treatment of inoperable patients suffering from severe functional mitral regurgitation. The company was founded by Laura Figulla and Till Neumann in 2013 and is headquartered in Munich, Germany. | Directeur Technique/Scientifique/R&D | - |
Micro-Motor AG
 Micro-Motor AG Electrical ProductsProducer Manufacturing Micro-Motor AG develops and manufactures electric drives. The firm also engages in the development, production, and distribution of electro motors and drive systems for use in wheel chairs, stair lifts, warehouse handling systems, curtain tracks and similar applications. The company was founded 1941 and is headquartered in Therwil, Switzerland. | Directeur Général | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Micro-Motor AG
Micro-Motor AG Electrical ProductsProducer Manufacturing Micro-Motor AG develops and manufactures electric drives. The firm also engages in the development, production, and distribution of electro motors and drive systems for use in wheel chairs, stair lifts, warehouse handling systems, curtain tracks and similar applications. The company was founded 1941 and is headquartered in Therwil, Switzerland. | Producer Manufacturing |
coramaze technologies GmbH
coramaze technologies GmbH Medical SpecialtiesHealth Technology coramaze technologies GmbH operates as a medical device company which develops valve repair system. It offers mitramaze a novel concept for transcatheter mitral valve repair intended for treatment of inoperable patients suffering from severe functional mitral regurgitation. The company was founded by Laura Figulla and Till Neumann in 2013 and is headquartered in Munich, Germany. | Health Technology |
